Evidence map›Paper›PMID 38130195›Full record

ArticleZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery2023

[Preparation of berberine-naringin dual drug-loaded composite microspheres and evaluation of their antibacterial-osteogenic properties].

Wei Xiong, Lingmei Yuan, Liangxia Wang, Guowen Qian, Chaoyi Liang, Bin Pan, Ling Guo, Wenqiang Wei, Xunxiang Qiu, Wenfang Deng and 1 more

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Wei XiongGraduate School, Jiangxi University of Traditional Chinese Medicine, Nanchang Jiangxi, 330004, P. R. China.
Lingmei YuanDepartment of Ophthalmology, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang Jiangxi, 330006, P. R. China.
Liangxia WangDepartment of Traumatic Orthopedics, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang Jiangxi, 330006, P. R. China.
Guowen QianInstitute of International Innovation, Jiangxi University of Science and Technology, Nanchang Jiangxi, 330013, P. R. China.
Chaoyi LiangGraduate School, Jiangxi University of Traditional Chinese Medicine, Nanchang Jiangxi, 330004, P. R. China.
Bin PanGraduate School, Jiangxi University of Traditional Chinese Medicine, Nanchang Jiangxi, 330004, P. R. China.
Ling GuoGraduate School, Jiangxi University of Traditional Chinese Medicine, Nanchang Jiangxi, 330004, P. R. China.
Wenqiang WeiGraduate School, Jiangxi University of Traditional Chinese Medicine, Nanchang Jiangxi, 330004, P. R. China.
Xunxiang QiuGraduate School, Jiangxi University of Traditional Chinese Medicine, Nanchang Jiangxi, 330004, P. R. China.
Wenfang DengGraduate School, Jiangxi University of Traditional Chinese Medicine, Nanchang Jiangxi, 330004, P. R. China.
Zhikui ZengDepartment of Traumatic Orthopedics, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang Jiangxi, 330006, P. R. China.
Jiangxi University of Traditional Chinese Medicine · CNAffiliated Hospital of Jiangxi University of Traditional Chinese Medicine · CNJiangxi University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To develop a drug-loaded composite microsphere that can simultaneously release the berberine (BBR) and naringin (NG) to repair infectious bone defects. Methods: The NG was loaded on mesoporous microspheres (MBG) to obtain the drug-loaded microspheres (NG-MBG). Then the dual drug-loaded compound microspheres (NG-MBG@PDA-BBR) were obtained by wrapping NG-MBG with polydopamine (PDA) and modifying the coated PDA with BBR. The composite microspheres were characterized by scanning electron microscopy, X-ray diffraction, specific surface area and pore volume analyzer, and Fourier transform infrared spectroscopy; the drug loading rate and release of NG and BBR were measured; the colony number was counted and the bacterial inhibition rate was calculated after co-culture with Results: NG-MBG@PDA-BBR and three control microspheres (MBG, MBG@PDA, and NG-MBG@PDA) were successfully constructed. Scanning electron microscopy showed that NG-MBG@PDA-BBR had a rough lamellar structure, while MBG had a smooth surface, and MBG@PDA and NG-MBG@PDA had a wrapped agglomeration structure. Specific surface area analysis showed that MBG had a mesoporous structure and had drug-loading potential. Low angle X-ray diffraction showed that NG was successfully loaded on MBG. The X-ray diffraction pattern contrast showed that all groups of microspheres were amorphous. Fourier transform infrared spectroscopy showed that NG and BBR peaks existed in NG-MBG@PDA-BBR. NG-MBG@PDA-BBR had good sustained drug release ability, and NG and BBR had early burst release and late sustained release. NG-MBG@PDA-BBR could inhibit the growth of Conclusion: NG-MBG@PDA-BBR have sustained release effects on NG and BBR, indicating that it has ideal dual performance of osteogenesis and antibacterial property.

Indexed as

BerberineOsteogenesisAnimalsAnthraquinonesAnti-Bacterial AgentsDelayed-Action PreparationsEscherichia coliFlavanonesMicrospheresRatsalizarinAnthraquinonesAnti-Bacterial AgentsBerberineDelayed-Action PreparationsFlavanonesnaringinantibacterial propertyberberineMesoporous bioactive glassesosteogenesispolydopamine

Identifiers

PMID38130195
PMCPMC10739667
OpenAlexW4390120476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.